Christopher D. Verrico
Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher D. Verrico as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:37 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07218549 · Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid UseChristopher D. Verrico · recruiting · Opioid Use, Substance Use Disorders, Opioid Analgesia
- Ph2NCT06454669 · Dronabinol as an Adjunct for Reducing PainChristopher D. Verrico · recruiting · Low Back Pain, Chronic Pain, Back Injuries
- Ph1NCT06252623 · Exenatide For Reducing the Reinforcing Effects of CocaineChristopher D. Verrico · withdrawn · Cocaine Use Disorder
- Ph2NCT04360681 · Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in VeteransPharmacotherapies for Alcohol and Substance Use Disorders Alliance · completed · Post Traumatic Stress Disorder, Opioid-use Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A human abuse potential study of kratomU01FD008327 · FDA · BAYLOR COLLEGE OF MEDICINE · fiscal years 2024 to 2026 · $1,877,389 awarded in 2026Same name and institution; not confirmed by an ID
- A Human Laboratory Study of Exenatide for Reducing the Reinforcing Effects of CocaineR21DA057411 · NIDA · BAYLOR COLLEGE OF MEDICINE · fiscal years 2023 to 2024 · $199,265 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:37 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.Nicotine Tob Res · 2021105 citationsRCR 7.2
- The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder.BMC Psychiatry · 201950 citationsRCR 3.1
- Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Drug Alcohol Depend · 201435 citationsRCR 1.4
- Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.J Clin Psychiatry · 201632 citationsRCR 1.7
- Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.Int J Neuropsychopharmacol · 201420 citationsRCR 0.9
- Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.Prog Neuropsychopharmacol Biol Psychiatry · 201414 citationsRCR 0.6
- Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.Int J Neuropsychopharmacol · 201614 citationsRCR 0.7
- Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder.Int J Neuropsychopharmacol · 201513 citationsRCR 0.6
- Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.Psychiatry Res · 201512 citationsRCR 0.5
- Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.Neuropharmacology · 201411 citationsRCR 0.5